Actively Recruiting

Age: 18Years +
All Genders
NCT07243964

Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation

Led by Chang Chen · Updated on 2025-11-24

244

Participants Needed

1

Research Sites

225 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

By establishing a prospective, multicenter lung transplantation clinical cohort, this study aims to systematically evaluate the utility of cfDNA fragmentomics, peripheral blood single-cell sequencing, and proteomics in monitoring and predicting graft dysfunction after lung transplantation, and to develop a multi-omics predictive model for early identification, dynamic monitoring, and mechanistic investigation of acute lung allograft dysfunction (ALAD) and chronic lung allograft dysfunction (CLAD).

CONDITIONS

Official Title

Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Recipients aged 9 years undergoing single or double lung transplantation
  • Postoperative recipients capable of understanding and providing written informed consent, and willing to comply with scheduled follow-ups and sample collections as required by the study
  • Postoperative recipients clinically assessed as stable and eligible for routine follow-up and hematological examinations
  • Recipients able to undergo dynamic pulmonary function monitoring during follow-up
  • No planned participation in other interventional trials during the study period that may impact immune function or pulmonary function
  • Retransplant patients will be considered as a new transplant event and may be included in the analysis
Not Eligible

You will not qualify if you...

  • History of active malignancy or presence of untreated malignancy within 5 years prior to transplantation
  • Presence of active systemic infection or significant immune rejection
  • Female patients who are pregnant or lactating
  • Any other condition deemed by the investigator to be inappropriate for inclusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shanghai Pulmonary Hospital

Shanghai, China

Actively Recruiting

Loading map...

Research Team

J

Junqi Wu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here